FR2918376B1 - Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage - Google Patents

Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage

Info

Publication number
FR2918376B1
FR2918376B1 FR0756271A FR0756271A FR2918376B1 FR 2918376 B1 FR2918376 B1 FR 2918376B1 FR 0756271 A FR0756271 A FR 0756271A FR 0756271 A FR0756271 A FR 0756271A FR 2918376 B1 FR2918376 B1 FR 2918376B1
Authority
FR
France
Prior art keywords
passized
proteoglycans
contribution
constitution
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0756271A
Other languages
English (en)
Other versions
FR2918376A1 (fr
Inventor
Mathieu Borge
Patrick Laduree
Laurence Paris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0756271A priority Critical patent/FR2918376B1/fr
Priority to PCT/FR2008/051250 priority patent/WO2009007660A1/fr
Priority to EP08826103A priority patent/EP2162491A1/fr
Priority to US12/666,790 priority patent/US20100210584A1/en
Publication of FR2918376A1 publication Critical patent/FR2918376A1/fr
Application granted granted Critical
Publication of FR2918376B1 publication Critical patent/FR2918376B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
FR0756271A 2007-07-04 2007-07-04 Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage Expired - Fee Related FR2918376B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0756271A FR2918376B1 (fr) 2007-07-04 2007-07-04 Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage
PCT/FR2008/051250 WO2009007660A1 (fr) 2007-07-04 2008-07-04 Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage
EP08826103A EP2162491A1 (fr) 2007-07-04 2008-07-04 Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage
US12/666,790 US20100210584A1 (en) 2007-07-04 2008-07-04 Liquid or paste compositions intended to provide elements essential for the synthesis and formation of proteoglycans, in particular, for the treatment of cartilage degradation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0756271A FR2918376B1 (fr) 2007-07-04 2007-07-04 Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage

Publications (2)

Publication Number Publication Date
FR2918376A1 FR2918376A1 (fr) 2009-01-09
FR2918376B1 true FR2918376B1 (fr) 2011-10-28

Family

ID=38996680

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0756271A Expired - Fee Related FR2918376B1 (fr) 2007-07-04 2007-07-04 Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage

Country Status (4)

Country Link
US (1) US20100210584A1 (fr)
EP (1) EP2162491A1 (fr)
FR (1) FR2918376B1 (fr)
WO (1) WO2009007660A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314018B2 (en) * 2012-06-25 2016-04-19 Institut de Recherche en Semiochimie et Ethologie Appliquee Feline scratch marking semiochemicals
FR3009963B1 (fr) * 2013-09-03 2017-03-03 Biolis Composition de lutte contre les troubles de la locomotion
US9682099B2 (en) * 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
WO2019031529A1 (fr) * 2017-08-10 2019-02-14 ネステク ソシエテ アノニム Boisson
CN115737910B (zh) * 2021-09-03 2024-04-05 青岛农业大学 一种促进软骨高效分泌粘多糖的硫酸软骨素/甘油二酯纳米乳液制备方法

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503563A1 (fr) 1981-04-09 1982-10-15 Pos Lab Composition pour collyre a base de sulfate de chondroitine a
US5916565A (en) 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
US20020025921A1 (en) 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
US6476005B1 (en) 1998-03-24 2002-11-05 George D. Petito Oral and injectable nutritional composition
US6482401B1 (en) 1998-12-23 2002-11-19 Naturopathic Laboratories International, Inc. Composition for the relief of joint pain and myofascial pain and method of preparing same
DE19859771C1 (de) * 1998-12-23 2000-08-24 Sueddeutsche Kalkstickstoff Wasserlösliche, stabile Brenztraubensäure(-salze)-enthaltende Formulierung
US7851458B2 (en) 1999-06-22 2010-12-14 Joint Juice, Inc. Cartilage enhancing food supplements and methods of preparing the same
US20030124200A1 (en) 1999-06-22 2003-07-03 Stone Kevin R. Cartilage enhancing food supplements with sucralose and methods of preparing the same
JP2001039408A (ja) 1999-07-29 2001-02-13 Toyo Jidoki Co Ltd 袋の整形装置を備えた縦型真空包装装置
KR20010018321A (ko) 1999-08-18 2001-03-05 박명환 류마티스 관절염 환자를 위한 건강식품 조성물
KR20010046562A (ko) 1999-11-12 2001-06-15 박명환 골 관절염 치료를 위한 건강식품 조성물
US6358526B1 (en) * 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
US6767899B1 (en) 2000-08-29 2004-07-27 Leiner Health Services Corp. Composition and method for treatment of conditions having an inflammatory component
US6924273B2 (en) 2000-10-03 2005-08-02 Scott W. Pierce Chondroprotective/restorative compositions and methods of use thereof
US20030229049A1 (en) 2000-10-31 2003-12-11 Eek Bjorn C.J. Method and pharmaceutical to treat spinal discs
US20020099032A1 (en) 2000-11-10 2002-07-25 Kiyotsugu Higashi Preparations and method of producing the same
US6413552B1 (en) 2000-11-27 2002-07-02 David M. Stoll Topically applied creatine containing composition
JP4754066B2 (ja) 2000-12-22 2011-08-24 株式会社林原生物化学研究所 抗関節障害剤
KR100463414B1 (ko) 2001-08-09 2004-12-23 주식회사 파시코 스포츠인용 보조식품
US20050101563A1 (en) 2001-08-14 2005-05-12 Pharmacia Corporation Method and compositions for the treatment and prevention of pain and inflammation
US20030138543A1 (en) 2002-01-03 2003-07-24 Bradley T. Baumann Food product supplemented with proteoglycan precursors
US20030134825A1 (en) * 2002-01-03 2003-07-17 Robert Bahoshy Food product supplemented with proteoglycan precursors
JP2005519914A (ja) * 2002-01-23 2005-07-07 インスティチュート オブ ニュートラシューティカル リサーチ ピーティーワイ リミテッド 結合組織の治療、防御および回復のためのニュートラシューティカルズ（ｎｕｔｒａｃｅｕｔｉｃａｌｓ）
US20030155736A1 (en) 2002-02-20 2003-08-21 Ludvigsen Calvin Dean Tension fitting, distortion fender
KR20030092698A (ko) 2002-05-30 2003-12-06 주식회사 한국생명공학 칼슘 보충용 건강 보조 식품 및 그 제조 방법
US20040029774A1 (en) * 2002-08-06 2004-02-12 Aly Gamay Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies
US6660308B1 (en) 2002-09-11 2003-12-09 Kenneth A. Martin Beverage and additive for the ill
US6979458B1 (en) * 2002-09-11 2005-12-27 Kenneth A. Martin Beverage and additive for wellness
WO2004034980A2 (fr) 2002-10-16 2004-04-29 Marcum Frank D Traitement de la synovite traumatique et des lesions du cartilage articulaire
US7504387B2 (en) 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
CA2446615C (fr) 2002-11-05 2009-02-03 George D. Petito Composition nutritionnelle pour le traitement du tissu conjonctif
CN1511549A (zh) 2002-12-27 2004-07-14 张小丽 含有黄芩的抗肿瘤、抗炎症及肿瘤预防药物的组合物
US7618657B2 (en) 2003-02-21 2009-11-17 Ultra Biotech Limited Active ingredients preparation and single compound purification from traditional Chinese herbal medicine Fructus Trichosanthis and uses thereof
CN100339014C (zh) 2003-03-27 2007-09-26 中国人民解放军第三军医大学 N－乙酰氨基葡萄糖在乳制品中的应用及包含n－乙酰氨基葡萄糖的乳制品
CN1534088A (zh) 2003-03-27 2004-10-06 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖作为添加剂在啤酒中的应用及包含n-乙酰氨基葡萄糖的啤酒
CN1534089A (zh) 2003-03-27 2004-10-06 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖作为添加剂在葡萄酒中的应用及包含n-乙酰氨基葡萄糖的葡萄酒
KR20040100009A (ko) 2003-05-21 2004-12-02 조영재 지에이지(ｇａｇ) 제제를 함유한 관절염 치료기용초음파용 젤
US20040254142A1 (en) 2003-06-12 2004-12-16 Robert Kovler Arthritic and joint condition formulation
ITMI20031311A1 (it) 2003-06-27 2004-12-28 Indena Spa Formulazioni per il trattamento di disturbi artrosici.
JP2004002482A (ja) 2003-09-09 2004-01-08 Rohto Pharmaceut Co Ltd アミノ糖含有製剤
WO2005041999A1 (fr) 2003-10-21 2005-05-12 Motion Potion, Inc. Composition destinee a ameliorer la fonction et la reparation des articulations
KR20040004346A (ko) 2003-12-23 2004-01-13 장태순 염증성 질환 예방 또는 개선용 식품 조성물 및 그 제조방법
WO2005087202A1 (fr) 2004-02-10 2005-09-22 Ranbaxy Laboratories Limited Complexe interpolymere de glucosamine polyacrylate et procedes de production correspondants
JP2005225782A (ja) 2004-02-10 2005-08-25 Api Co Ltd タブレット用組成物
US20050181047A1 (en) 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
WO2005116086A2 (fr) 2004-04-07 2005-12-08 The University Of Georgia Research Foundation, Inc. Glucosamine et promédicaments mutuels anti-inflammatoires, compositions et procédés à base de glucosamine
US20050232980A1 (en) 2004-04-15 2005-10-20 Chen Andrew L Transdermal chondroitin and glucosamine delivery system and method of use
US7153975B2 (en) 2004-06-18 2006-12-26 North Carolina State University Boron complexation strategy for use in manipulating 1-acyldipyrromethanes
US20050282772A1 (en) 2004-06-21 2005-12-22 Gokaraju Ganga R New dietary supplement composition for obesity and inflammation
ES2255829B1 (es) 2004-08-06 2007-08-16 Bioiberica, S.A. Nuevo uso de sales de glucosamina.
US7455860B2 (en) 2004-08-11 2008-11-25 Laila Nutraceuticals Dietary supplement formulation for controlling inflammation and cancer
RU2260432C1 (ru) 2004-10-12 2005-09-20 Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм") Средство для лечения болезней суставов
US7128698B2 (en) 2004-11-22 2006-10-31 Tessema Dosho Shifferaw Air resistance exercise device and method
EP1814518A1 (fr) 2004-11-23 2007-08-08 Alcon Inc. Composition viscoelastique a trois polymeres naturels
DE202005006527U1 (de) 2005-04-22 2005-07-14 Analyze & Realize Ag Gelenkpräparat
CA2493947A1 (fr) 2005-01-20 2006-07-20 Martin Lee Arthro gel et syner gel
BE1015783A6 (fr) 2005-04-07 2005-08-02 Trenker Adolphe Rodolphe Ferdi Composition pour la prevention et le traitement de l'osteoporose et de l'arthrose.
JP2008542300A (ja) 2005-05-24 2008-11-27 ウェルルゲン インコーポレーテッド 炎症と関連した状態を予防及び治療するための組成物及び方法
RU2292201C1 (ru) 2005-05-30 2007-01-27 Пятигорская государственная фармацевтическая академия Композиция - мягкая лекарственная форма противоартрозного действия, содержащая диклофенак и глюкозамина гидрохлорид для ректального применения
US20060292250A1 (en) 2005-06-23 2006-12-28 Suracell, Inc. Supplement composition and method of use for enhancement of anti-inflammation process
KR100809584B1 (ko) 2005-06-30 2008-03-06 아미코젠주식회사 글루코사민과 피니톨을 유효성분으로 하는 염증성 질환의예방 및 치료용 조성물
US20070048386A1 (en) 2005-08-30 2007-03-01 Mallozzi Ottavio Sr Medicament for treating inflammatory and non-inflammatory arthritis
CA2556343A1 (fr) 2005-09-01 2007-03-01 Purepharm Inc. Formulations nutritionnelles synthetiques
DE202005017053U1 (de) * 2005-10-28 2006-01-05 Weber & Weber Gmbh & Co. Kg Nährstoffpräparat, insbesondere geeignet für die nutritive Ergänzung bei erhöhter Gelenkbeanspruchung und Gelenkerkrankungen

Also Published As

Publication number Publication date
FR2918376A1 (fr) 2009-01-09
EP2162491A1 (fr) 2010-03-17
WO2009007660A9 (fr) 2011-07-28
US20100210584A1 (en) 2010-08-19
WO2009007660A1 (fr) 2009-01-15

Similar Documents

Publication Publication Date Title
CL2011000663A1 (es) Compuestos derivados de n-heterociclil-2-sulfonil acetamida, moduladores del receptor cb2, utiles para el tratamiento del dolor, enfermedad pulmonar, reumatica, autoinmune, entre otras.
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
CL2007002169A1 (es) Compuestos derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso del compuesto para prevenir o tratar la inflamacion, trastornos urologicos, gastrointestina
MX2022009942A (es) Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
EP2152318A4 (fr) Compositions et utilisations pour le traitement du psoriasis et de la maladie de crohn
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
DK3067057T3 (da) Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier
CL2007002272A1 (es) Compuestos derivados de n-metil-c-normorfinano; composicion farmaceutica; y uso para la reduccion de efectos secundarios del tratamiento de opioides tales como constipacion y nauseas, y para tratar trastornos mediados por la actividad de receptores o
UA92636C2 (en) Tetrahydro-pyrimidoazepines as modulators of trpv1
EP2061788A4 (fr) Nouvelles compositions et procédés pour le traitement de maladies associées à des lymphocytes activés
FR2918376B1 (fr) Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage
ZA201200999B (en) Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders
IL216149A (en) Heterocyclic phenoxymethyl compounds, their pharmaceutical preparations and their use in the preparation of drugs for the treatment of central nervous system disorders
FR2899476B1 (fr) Association du mazindol dans le traitement du deficit de l'attention/hyperactivite
IL208782A0 (en) Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
CY1111588T1 (el) Υποκατεστημενα καρβοξαμιδια ως ανταγωνιστες μεταβολοτροπου υποδοχεα ομαδας ι
FR2920309B1 (fr) Utilisation de travoprost pour traiter la chute des cheveux
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen
FR2906468B1 (fr) Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
IL199214A (en) A product containing a combination of pamirolast and statin, pharmaceuticals and kits containing it and their uses in the treatment of inflammatory conditions
BRPI0809837A2 (pt) "composto para tratamento de distúrbios mentais, saldo do composto para tratamento de distúrbios mentais, composição farmacéutica e uso do composto para tratamento de distúrbios mentais"
FR2937868B1 (fr) Composes antagonistes des recepteurs de la melanocortine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2917086B1 (fr) Nouveaux derives d'acide 3-phenyl acrylique activateurs des recepteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
FR2917947B1 (fr) Composition phytosanitaire pour le traitement preventif et curatif du mildiou
BRPI0916080A2 (pt) "composição de limpeza pessoal líquida ou sólido-macia"

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160331